BMJ critiques Pfizer data: efficiacy waning

Here’s at link to Peter Doshi’s devastating BMJ critique of the Pfizer vaccine data. Which leaves the Israel experience as our most reliable current guide – and Israel is reporting efficiacy below 40%.
In short, there is “no reported data past 13 March 2021, unclear efficacy after six months due to unblinding, evidence of waning protection irrespective of the Delta variant, and limited reporting of safety data. (The preprint reports “decreased appetite, lethargy, asthenia, malaise, night sweats, and hyperhidrosis were new adverse events attributable to BNT162b2 not previously identified in earlier reports,” but provides no data tables showing the frequency of these, or other, adverse events.)